Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking.

Sci Rep · 2018 · PMC5797108 · PMID 29396470

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Engagement of CD134 on human NK cells with an agonistic mAb increased ADCC capacity, IFNγ secretion and showed a trend towards greater TNFα release.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.